lungPRC

33 posts

lungPRC banner
lungPRC

lungPRC

@LungPrc

We are a research consortium studying the delivery of lung cancer screening and associated outcomes. Posts on this page do not reflect the opinions of the NIH.

Katılım Temmuz 2021
17 Takip Edilen32 Takipçiler
lungPRC retweetledi
Annals of Int Med
Annals of Int Med@AnnalsofIM·
Kick off the New Year by catching up on your reading. Annals Editor-in-Chief @ClaineMD will help you get started. She and the Annals editors have curated a list of must-read articles at ow.ly/MqeH50QmS3j. Happy reading!
Annals of Int Med tweet media
English
0
4
9
3.2K
lungPRC
lungPRC@LungPrc·
@IASLC featured the paper recently published in @JTOonline in their September 2022 newsletter! Below is a link to the press release for this publication, posted earlier this month shar.es/afuVMM
English
1
1
2
0
lungPRC
lungPRC@LungPrc·
This issue highlights PROSPR's data share; a fantastic resource for external researchers to use the data that our consortium has collected! Read the article for more information about this exciting development!
English
0
0
1
0
lungPRC retweetledi
Kate Rendle, PhD (she/her)
Kate Rendle, PhD (she/her)@kate_rendle·
Important findings led by @AnilVachani & PROSPR that #LCSM in US community practice may be shifting #lungcancer detection toward earlier stages @LungPrc @NCICareDelivRes
JTO & JTO CRR@JTOonline

Implementing #lungcancer screening at 4 diverse healthcare systems resulted in an 8.4% increase in the number of Stage I lung cancers detected, and a 6.6% decrease in Stage IV disease according to research published in the @JTOonline Read More: bit.ly/3KV87ds #LCSM

English
0
4
9
0
lungPRC
lungPRC@LungPrc·
@JTOonline New publication from PROSPR Lung Research center. This study included patients from the Kaiser Permanente Colorado and Hawaii regions along with Henry Ford health system and Penn medicine. @RitzwollerDebra @NCICareDelivRes
English
0
0
0
0
JTO & JTO CRR
JTO & JTO CRR@JTOonline·
Implementing #lungcancer screening at 4 diverse healthcare systems resulted in an 8.4% increase in the number of Stage I lung cancers detected, and a 6.6% decrease in Stage IV disease according to research published in the @JTOonline Read More: bit.ly/3KV87ds #LCSM
JTO & JTO CRR tweet media
English
2
3
19
0
lungPRC
lungPRC@LungPrc·
@RogerKimMD 's exciting work on racial disparities in lung cancer screening adherence was presented at the NCI Board of Scientific Advisors Meeting on March 29! The LOTUS team is always thrilled to share our work with our partners at @NIH.
lungPRC tweet media
English
2
4
6
0
lungPRC retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
#TTLC22 Nikki Carroll presents P15 which shows real world treatment trends for pts with NSCLC through the PROSPR consortium. Use of 1L IO increased over time. Data up to 2018 so expect (hope for) a large jump with the next update. Use of targeted therapy though seems low. #LCSM
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
0
3
4
0
lungPRC
lungPRC@LungPrc·
Officially accepted in Sept 2021, “Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: the PROSPR Consortium” is now available in the March issue of @AnnalsATS! Congratulations to Andrea Burnett-Hartman and co-authors!
English
1
1
1
0